Modelling the joint association of socio-economic disadvantage, diabetes, and obesity on COVID-19 mortality in Greater Mexico City.

Publication date: Jul 04, 2025

The impact of Coronavirus disease 2019 (COVID-19) has severely affected populations with lower socioeconomic background and with certain comorbidities. Many studies have examined the effect of poor socioeconomic conditions or specific comorbidities separately on COVID-19 mortality. However, it is important to understand the joint effect of deprived socioeconomic conditions and specific comorbidities on COVID-19 mortality. Such a joint effect may play a different role in dying of COVID-19, when compared with the effect of deprived socioeconomic conditions and comorbidities separately. Therefore, this study investigates the joint association of deprived socioeconomic background and severe comorbidities (diabetes and obesity) on COVID-19 mortality, in Greater Mexico City. The study used official Mexican COVID-19 data at the individual and municipal level. The results illustrate significant and positive association of the socioeconomic deprivation index along with diabetes and obesity on COVID-19 mortality. This underscores the need for individualized, targeted, and public interventions that consider the role of lower socioeconomic status and specific comorbidities to reduce mortality.

Open Access PDF

Concepts Keywords
Coronavirus Adult
Diabetes Aged
Mexican Comorbidity
Socioeconomic COVID-19
COVID-19
Diabetes
Diabetes Mellitus
Female
Humans
Inequality
Male
Mexico
Mexico
Middle Aged
Obesity
Obesity
SARS-CoV-2
Social Class
Socioeconomic Factors

Semantics

Type Source Name
disease MESH obesity
disease MESH COVID-19
disease IDO role
disease MESH Long Covid
disease MESH emergency
disease MESH comorbidity
disease MESH death
disease MESH diabetes mellitus
disease MESH hypertension
disease MESH cancer
disease IDO country
drug DRUGBANK Coenzyme M
drug DRUGBANK Water
disease MESH Piedra
disease MESH low socioeconomic status
disease MESH asthma
pathway KEGG Asthma
disease MESH chronic conditions
disease IDO quality
disease MESH chronic kidney disease
disease MESH cardiovascular disease

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *